- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Seen as Future of Medicaid
Roughly 85% of Medicaid enrollees will be in managed care organizations by 2020, a health consultant and former state Medicaid director predicted here.
Roughly 85% of Medicaid enrollees will be in managed care organizations by 2020, a health consultant and former state Medicaid director predicted here.
That's in contrast to today, when currently nearly half of Medicaid enrollees are in managed care and roughly 78% of reimbursements come from fee-for-service, said Vern Smith, PhD, managing principal at Health Management Associates in Naples, Fla.
"There is tremendous upside potential for serving this population going forward," Smith told the audience in his keynote address at the annual conference of the Medicaid Health Plans of America (MHPA), a national trade group of Medicaid health plans.
As Medicaid becomes a larger chunk of state budgets and enrollment grows under Medicaid expansion of the Affordable Care Act, states are turning to managed care to better handle costs, especially for certain populations, said Smith, a former Medicaid director in Michigan.
Michael Rashid, MHPA board chair, too noted the increase in Medicaid managed care during his address. "Traditional fee-for-service Medicaid -- to be honest -- has become a thing of the past," Rashid said.
Read the full story here: http://bit.ly/18Derix
Source: MedPage Today
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
